Assay Designs Ann Arbor Mi

Lab Reagents

Human IgG antibody Laboratories manufactures the assay designs ann arbor mi reagents distributed by Genprice. The Assay Designs Ann Arbor Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Arbor Assays. Other Assay products are available in stock. Specificity: Assay Category: Designs Group: Ann Arbor

Ann Arbor information

Assay Buffer Concentrate, 55ML

X088-55ML 55ML
EUR 171.6

Assay Buffer Concentrate, 25ML

X106-25ML 25ML
EUR 130.8

Assay Buffer Concentrate, 28ML

X111-28ML 28ML
EUR 147.6

Assay Buffer Concentrate, 28ML

X112-28ML 28ML
EUR 147.6

Assay Buffer Concentrate, 25ML

X121-25ML 25ML
EUR 130.8

Assay Buffer Concentrate, 28ML

X122-28ML 28ML
EUR 147.6

Assay Buffer Concentrate, 28ML

X132-28ML 28ML
EUR 147.6

MI-2

A3602-10 10 mg
EUR 338.4
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-200 200 mg
EUR 1869.6
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-5 5 mg
EUR 254.4
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-5.1 10 mM (in 1mL DMSO)
EUR 498
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-50 50 mg
EUR 756
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-3

A3603-10 10 mg
EUR 480
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-100 100 mg
EUR 1863.6
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-5 5 mg
EUR 320.4
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-5.1 10 mM (in 1mL DMSO)
EUR 370.8
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-50 50 mg
EUR 1461.6
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.